Cover Image
Market Research Report

Europe Diabetes Care Devices Market - Segmented by Product and Geography - Growth, Trends, and Forecast (2018 - 2023)

Published by Mordor Intelligence LLP Product code 390761
Published Content info 90 Pages
Delivery time: 2-3 business days
Back to Top
Europe Diabetes Care Devices Market - Segmented by Product and Geography - Growth, Trends, and Forecast (2018 - 2023)
Published: April 1, 2018 Content info: 90 Pages

The Europe diabetes care devices market is expected to register a CAGR of about 6.2% during 2018-2023 (the forecast period). Germany is likely to dominate the market during the forecast period, owing to the rising prevalence of diabetes and obesity in the country.

Rising Prevalence of Diabetes and Obesity

According to World Health Organization (WHO), about 60 million people live with diabetes in Europe. About 10.3% of men and 9.6% of women, aged 25 years and over, are suffering from diabetes. The prevalence of diabetes is growing among all ages in Europe, which can be attributed to the growing obese population, along with unhealthy diets and sedentary lifestyles of people. Furthermore, approximately 112,000 children and adolescents are estimated to live with Type 1 diabetes in the region. Countries, such as the United Kingdom and Germany, witness a huge number of Type 1 diabetics, especially among the youth population. Thus, rising prevalence of diabetes and obesity, growing awareness ,regarding diabetic care, healthcare expenditure, and technological advancements are a few factors that are further driving the market for diabetes care devices in Europe.

Sluggish Economy Scenario in Europe

The sluggish economy in most European countries and the short-term cost containment measures that followed have made Europe a tough place for most healthcare companies to establish in. In the largely publicly-funded European healthcare systems, the governments have been trying to drive down prices, which makes it difficult to obtain an apt price for new products that would justify the R&D costs involved. Moreover, reimbursement restrictions often prevent innovative products from reaching patients. The sluggish economic scenario, coupled with high cost associated with diagnosis and treatment, is the major restraint for this market growth.

Germany to Dominate the Market

Germany is dominating the Europe diabetes care devices market. This growth can be attributed to the fact that, patients and physicians are steadily adopting new technologically advanced products to regularly screen and monitor diabetic conditions. The United Kingdom is anticipated to grow tremendously during the forecast period, owing to the factors, such as a rising prevalence of diabetes and awareness, regarding preventive care, coupled with high healthcare expenditure.

Key Developments in the Market

January 2018 - Eli Lilly and Company and Livongo Health, a leading consumer digital health company, announced a strategic collaboration to study real-world evidence and develop new insights, so as to reduce the burden on people living with diabetes.

June2017 - Roche acquired mySugr to form a leading open platform for digital diabetes management.


Reasons to Purchase this Report

Current and future Europe diabetes care devices market outlook in the developed and emerging markets

Various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness the fastest rates growth during the forecast period

The latest developments, market shares, and strategies employed by the major market players

3 months analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

Table of Contents
Product Code: 56270

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Rising Incidence of Diabetes and Obesity
    • 6.1.2 Technological Advancement
    • 6.1.3 Growing Awareness regarding Diabetes Care
    • 6.1.4 Growing Healthcare Expenditure
  • 6.2 Market Restraints
    • 6.2.1 High Cost, Associated with Diagnosis and Treatment
    • 6.2.2 Sluggish Economy Scenario in Europe
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Product
    • 7.1.1 Glucose Monitoring Devices
      • Continuous Glucose Monitoring Device
      • Lancets
      • Self-monitoring Blood Glucose Meters
      • Testing Strips
    • 7.1.2 Insulin Delivery Devices
      • Insulin Jet Injectors
      • Insulin Syringes
      • Insulin Pumps
      • Insulin Pens
  • 7.2 By Geography
    • 7.2.1 Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
      • Rest of Europe

8. Competitive Landscape

  • 8.1 Mergers and Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Abbott
  • 9.2 Acon Laboratories, Inc.
  • 9.3 Bayer AG
  • 9.4 Becton, Dickinson and Company
  • 9.5 Eli Lilly & Co.
  • 9.6 F. Hoffmann-La Roche Ltd
  • 9.7 Johnson and Johnson
  • 9.8 Medtronic PLC
  • 9.9 Novo Nordisk A/S
  • 9.10 Sanofi
  • 9.11 List Not Exhaustive

10. Future of the Market

Back to Top